Biosimilar - PDFSEARCH.IO - Document Search Engine

Biosimilar
Results: 639

#	Item
201	Biosimilar Medications Could Create Billions in Health Care Savings FOR RELEASE Monday November 3, 2014 Add to Reading List Source URL: www.womeningovernment.org Language: English - Date: 2014-11-14 15:28:59 Biosimilar Biotechnology Drugs Biologic Pharmaceuticals policy Food and Drug Administration Generic drug Copayment Hospira Pharmaceutical sciences Pharmacology Clinical research
202	Page Two July 30, 2014 Idaho State Board of Pharmacy 1199 West Shoreline Lane Add to Reading List Source URL: www.rheumatology.org Language: English Rheumatology Clinical pharmacology Biologic Rheumatoid arthritis Biosimilar Medical prescription Arthritis Patient safety Pharmacy Medicine Health Pharmacology
203	FDA Briefing Document Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) December 11, 2014 DISCLAIMER STATEMENT Add to Reading List Source URL: www.fda.gov Language: English Clinical pharmacology Food and Drug Administration Therapeutics United States Public Health Service Biosimilar Off-label use Food and Drug Administration Amendments Act Moxifloxacin Pharmacology Pharmaceutical sciences Clinical research
204	Shaping the biosimilars opportunity: A global perspective on the evolving biosimilars landscape Shaping the biosimilars opportunity: A global Add to Reading List Source URL: docs.340bpvp.com Language: English - Date: 2014-12-05 14:16:00 Biosimilar Biotechnology Drugs Hospira Biologic Etanercept Reditux Pharmaceutical industry Food and Drug Administration Pharmacology Pharmaceutical sciences Medicine
205	Microsoft Word - Dec[removed]Biosimilars_CE Page for PDF booklet_v2.docx Add to Reading List Source URL: www.proce.com Language: English - Date: 2014-11-26 17:54:12 Biosimilar American Society of Health-System Pharmacists Hospira Doctor of Pharmacy Clinical pharmacy Pharmacy school Pharmacist Pharmacy residency Biologic Pharmaceutical sciences Pharmacology Pharmacy
206	National Health Council 1730 M Street NW, Suite 500, Washington, DC[removed] ■ [removed] ■ www.nationalhealthcouncil.org ■ [removed] Response to Request for Information on the Strategy for American In Add to Reading List Source URL: www.nationalhealthcouncil.org Language: English - Date: 2014-12-16 12:43:21 MODDERN Cures Act Biosimilar Food and Drug Administration Pharmaceutical industry Clinical trial Dormant Therapy Drug Price Competition and Patent Term Restoration Act Pharmaceutical drug Patient safety organization Pharmaceutical sciences Pharmacology Clinical research
207	Safe Prescription, Safe Dispensing, Identification and Track&Trace of All Biologicals in the Context of the Re-opened Biosimilars INN Debate Add to Reading List Source URL: www.egagenerics.com Language: English - Date: 2014-12-27 09:50:22 Medicine Biosimilar Biotechnology Drugs Biologic Clinical pharmacology Identifier Medical prescription Nomenclature Pharmacology Clinical research Pharmaceutical sciences
208	Process on Corporate Social Reponsability in the Field of Pharmaceuticals Platform Access to Medicines in Europe Working Group Access and Uptake of Biosimilars Survey on good practices and obstacles of the market uptake Add to Reading List Source URL: www.egagenerics.com Language: English - Date: 2014-12-27 09:50:26 Biosimilar Biotechnology Drugs
209	Emergence of Biosimilar Medicines The Biosimilar Company Point of View Paul Greenland, Head of Biosimilars Business Unit - EMEA Belgium Federal Parliament Add to Reading List Source URL: www.egagenerics.com Language: English - Date: 2014-12-27 09:50:10 Medicine Pharmacology Biosimilar Biotechnology Drugs Cytokines Biologic Granulocyte colony-stimulating factor Erythropoietin Biology Amgen Growth factors
210	EuropaBio Statement on Labelling of Biosimilars September 2014 Transparent labelling is important to ensure that physicians and patients have readily available product-specific information about biosimilars, as is the ca Add to Reading List Source URL: www.europabio.org Language: English - Date: 2014-09-15 03:31:37 Biosimilar Drugs Clinical research Medicine Biologic Monoclonal antibodies Summary of Product Characteristics Biotechnology Pharmacology Biology

UPDATE